Item 1.

	(a)	Name of Issuer

		Foamix Pharmaceuticals Ltd.

	(b)	Address of Issuer’s Principal Executive Offices

		2 Holzman St., Weizmann Science Park, Rehovot L3 76704, Israel

Item 2.

	(a)	Name of Person Filing

		Great Point Partners, LLC Dr. Jeffrey R. Jay, M.D. Mr. David Kroin

		The Reporting Persons have entered into a Joint Filing Agreement, dated October 11, 2016, a copy of which is filed with this Schedule 13G as Exhibit A, pursuant to which the Reporting Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.

	(b)	Address of Principal Business Office, or if none, Residence

		The address of the principal business office of each of the Reporting Persons is

		165 Mason Street, 3rd Floor
		Greenwich, CT 06830

	(c)	Citizenship

	Great Point Partners, LLC is a limited liability company organized under the laws of the State of Delaware. Dr. Jeffrey R. Jay, M.D. is a citizen of the United States. Mr. David Kroin is a citizen of the United States.

	(d)	Title of Class of Securities

		Common Stock

	(e)	CUSIP Number

		M46135105

Item 3.	If this statement is filed pursuant to §240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

		Not Applicable.

	(a)	o	Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o)

	(b)	o	Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).

	(c)	o	Insurance company as defined in Section 3(a)(19) of the Act (15. U.S.C. 78c).

	(d)	o	Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

	(e)	o	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

	(f)	o	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).